175 related articles for article (PubMed ID: 27776666)
1. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy?
Peng C; Liu LZ; Zheng W; Xie YJ; Xiong YH; Li AH; Pei XQ
Eur J Radiol; 2016 Nov; 85(11):2111-2118. PubMed ID: 27776666
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis.
Zheng W; Xiong YH; Han J; Guo ZX; Li YH; Li AH; Pei XQ
Br J Radiol; 2016 Sep; 89(1065):20150887. PubMed ID: 27340932
[TBL] [Abstract][Full Text] [Related]
3. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
Sharma A; Grover SB; Mani C; Ahluwalia C
Br J Radiol; 2021 May; 94(1121):20201160. PubMed ID: 33860674
[TBL] [Abstract][Full Text] [Related]
4. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the early predictive power of quantitative magnetic resonance imaging parameters during neoadjuvant chemotherapy for uterine cervical cancer.
Himoto Y; Fujimoto K; Kido A; Matsumura N; Baba T; Daido S; Kiguchi K; Shitano F; Konishi I; Togashi K
Int J Gynecol Cancer; 2014 May; 24(4):751-7. PubMed ID: 24685827
[TBL] [Abstract][Full Text] [Related]
6. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
[TBL] [Abstract][Full Text] [Related]
7. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
Zhou SC; Le J; Fan YW; Chen M; Chang C
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
Zhang P; Chen Y; Liu J; Yang Y; Lv Q; Wang J; Zhang L; Xie M
Ultrasound Med Biol; 2018 Apr; 44(4):840-852. PubMed ID: 29395676
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
[TBL] [Abstract][Full Text] [Related]
10. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
11. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
12. Quantitative parameters of contrast-enhanced ultrasound in breast invasive ductal carcinoma: The correlation with pathological prognostic factors.
Ji CL; Li XL; He YP; Li DD; Gu XG; Xu HX
Clin Hemorheol Microcirc; 2017; 66(4):333-345. PubMed ID: 28387663
[TBL] [Abstract][Full Text] [Related]
13. Power Doppler vascularity index for predicting the response of neoadjuvant chemotherapy in cervical carcinoma.
Chen CA; Cheng WF; Lee CN; Su YN; Hsieh CY; Hsieh FJ
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):591-7. PubMed ID: 15144343
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound.
Li H; Lu J; Zhou X; Pan D; Guo D; Ling H; Yang H; He Y; Chen G
Ultrasound Med Biol; 2017 Oct; 43(10):2469-2476. PubMed ID: 28684184
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of effectiveness between intra-arterial and intra-venous neoadjuvant chemotherapy in stage Ib2-IIb cervical carcinoma].
Cao DY; Yang JX; Shen K; Xiang Y; Pan LY; Lang JH; Wu M; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):888-91. PubMed ID: 19134324
[TBL] [Abstract][Full Text] [Related]
18. The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
Perniola G; Tomao F; Graziano M; Palaia I; Fischetti M; Lecce F; Casorelli A; Di Donato V; Giancotti A; Battaglia FA; Muzii L; Benedetti Panici P
Oncology; 2020; 98(11):807-813. PubMed ID: 32892198
[TBL] [Abstract][Full Text] [Related]
19. [Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
CHEN XD; SHI HY; LÜ WG; QIN JL
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):173-6. PubMed ID: 21575388
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
